🟢 Ironwood Pharmaceuticals is trading 5% up today as broader markets rally

Ironwood Pharmaceuticals is trading 5.05% up now at $4.58 as broader markets rally; no September 21, 2026 company-specific catalyst has been identified.

• The S&P 500 and Nasdaq Composite are up 0.79% and 1.34%, respectively, supporting broader risk appetite.
• Recent LINZESS growth and apraglutide developments remain supportive background factors, but conference coverage does not explicitly link them to the current move.
• No fresh earnings, FDA, trial, guidance, or analyst catalyst has been identified.